Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-24-006706
Filing Date
2024-09-27
Accepted
2024-09-27 09:41:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2990
  Complete submission text file 0001959173-24-006706.txt   4443
Mailing Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107
Business Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107 626-305-5900
Xencor Inc (Subject) CIK: 0001326732 (see all company filings)

EIN.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36182 | Film No.: 241331057
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O BAXALTA INCORPORATED 1200 LAKESIDE DRIVE BANNOCKBURN IL 60015
Business Address
ROSA-BJORKESON DAGMAR (Reporting) CIK: 0001643934 (see all company filings)

Type: 144